Table 3 Pathological findings
Overall cohort, no. (%) | |
|---|---|
Tumor classification | |
pT0-Tis | 24 (20%) |
pT1 | 15 (12.5%) |
pT2 | 25 (20.8%) |
pT3 | 53 (44.2%) |
pT4 | 3 (2.5%) |
Tumor size, mma | 30 (0-160) |
Nodes classification | |
pN0 | 67 (55.8%) |
pN1 | 25 (20.8%) |
pN2 | 15 (12.5%) |
pN3 | 13 (10.8%) |
Stage | |
Stage 0 | 22 (18.3%) |
Stage I | 13 (10.8%) |
Stage II | 34 (28.3%) |
Stage III | 36 (30%) |
Stage IV | 15 (12.5%) |
Number of examined LNa | 17.5 (6-36) |
Number of mediastinal examined LN | 4 (0-16) |
Number of positive lymph nodesa | 3 (1-23) |
Perineural invasion | 22 (18.3%) |
Vascular embolism | 20 (16.7%) |
Tumor differentiation | |
Poor | 16 (13.3%) |
Intermediate | 37 (30.8%) |
Well | 41 (34.2%) |
Mucinous | 2 (1.7%) |
Sterilized tumor | 24 (20%) |
Margin status | |
R0 | 115 (95.8%) |
R1 | 5 (4.2%) |